US Patent Issued to IDORSIA PHARMACEUTICALS on July 1 for "Alkoxy-substituted pyridinyl derivatives as LPA1 receptor antagonists and their use in the treatment of fibrosis" (Swiss Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,344,597, issued on July 1, was assigned to IDORSIA PHARMACEUTICALS LTD (Allschwil, Switzerland).

"Alkoxy-substituted pyridinyl derivatives as LPA1 receptor antagonists and their use in the treatment of fibrosis" was invented by Martin Bolli (Allschwil, Switzerland), Christine Brotschi (Allschwil, Switzerland), Cyrille Lescop (Allschwil, Switzerland) and Jodi T. Williams (Allschwil, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to pyridinyl derivatives of Formula (I) Formula (I) wherein R1, R2, R3, R4, R5, R6, Ar1, L, W, Z, m and n are as described in the description, their preparation, to pharmaceutically accept...